NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VeriGraft

VeriGraft

Private
GothenburgHealthcare & Life Scienceshttps://verigraft.com/

Last Round

VC Round

Feb 12, 2026

Est. Valuation

$32.63M

Total Funding Raised

$2.44M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

VeriGraft is a biotechnology company that develops personalized tissue-engineered grafts for transplantation and tissue replacement.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Infrastructure

Keywords

tissue engineeringpersonalized graftstissue-engineered graftsclinical-stage biotechregenerative medicineimmunosuppressant-freebioengineered tissuedecellularizationtissue scaffoldChronic Venous InsufficiencyCVIAdvanced Therapy Medicinal ProductsATMPsvascular surgeryoff-the-shelf graftsbiomanufacturingAI in manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VeriGraft Comparables

Compare VeriGraft with similar companies based on industry and business-model similarity.

VeriGraft comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vascudyne
79%
enVVeno Medical Corporation
77%
Humacyte
77%

VeriGraft Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 12, 2026
CrowdfundingMar 14, 2025
GrantFeb 13, 2025
GrantDec 18, 2024
GrantNov 1, 2017

Key People

Founding team and executive leadership

Petter Björquist

CEO

Executive Team

Raimund Strehl

CTO

Executive Team

Edvard Nordfors

CFO

Executive Team

VeriGraft Investors

Notable investors and investment history

VeriGraft investors
InvestorRounds
Eurostars SME programmeGrant
VinnovaGrant
Horizon EuropeGrant
Capital CellCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2026

    $12.3M raised in a VC Round.

  • Jun 1, 2025

    Monthly visitors grew 297% MoM, from 109 to 433.

VeriGraft Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VeriGraft Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VeriGraft's valuation, stock price, and market status.

Firmographic Details

HeadquartersGothenburg
Employee Range18
Year Founded2014
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.